Oncology Biosimilars Market - Global Industry Size, Share, Trends Opportunity, and Forecast, 2028F

By Drug Class (Monoclonal Antibodies, G-CSF, Hematopoietic Agents, Others), By Type of Cancer (Breast Cancer, Lung Cancer, Stomach Cancer, Prostate Cancer, Cervical Cancer, Blood Cancer, Brain Cancer, Others), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies), By Region, Competition

Published	Pages	Publisher	Report code
Oct 2023	178	TechSci Research	ASDR-637875

Published: Oct 2023 - Pages : 178 - Publisher : TechSci Research - Report code : ASDR-637875

1. Teva Pharmaceuticals
2. STADA Arzneimittel AG
3. Shanghai Henlius Biotech Inc
4. Sandoz (Novartis) AG
5. Samsung Bioepis Co Ltd.
6. Pfizer Inc
7. Pfenex Inc.
8. Mylan Inc
9. Innovent Biologics Inc
10. Celltrion Healthcare Co Ltd

Oncology Biosimilars - Global Forecast 2024-2030

This report can be of interest as well:

Oncology Biosimilars - Global Forecast 2024-2030

Published: January, 2024 | Report code: ASDR-651102